The research dollars and venture capital flowing into Biotech has been astounding in 2005. Many regional economic development associations continue to look to Biotech as clean industry with high-paying jobs to spur on regional economic growth. Advances in cures for cancer, nanotech, artificial blood, vaccines and human computer interfaces all made headlines, as well as some ethical issues concerning stem cells, cloning and growing of body parts, tissue and skin. Transplants were also at the top of the scene by yearend as attempts were considered for brain transplants and an actual first face transplant was completed.

In fact there was so many no innovations and changes that were brought forth in 2005 that many alarmists were in fear of destroying the sanctity of life and crossing the line of what it is to be human. Their battle cry echoed thru the halls of Congress;